LOS ANGELES CAPITAL MANAGEMENT LLC - INTERSECT ENT INC ownership

INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 141 filers reported holding INTERSECT ENT INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
LOS ANGELES CAPITAL MANAGEMENT LLC ownership history of INTERSECT ENT INC
ValueSharesWeighting
Q1 2021$787,000
-14.6%
37,709
-6.4%
0.00%0.0%
Q4 2020$922,000
+34.0%
40,269
-4.6%
0.00%
+33.3%
Q3 2020$688,000
+57.4%
42,189
+30.8%
0.00%
+50.0%
Q2 2020$437,000
-49.7%
32,255
+19.5%
0.00%
-60.0%
Q1 2019$868,000
-1.8%
27,002
-13.9%
0.01%0.0%
Q4 2018$884,000
-23.1%
31,362
-21.5%
0.01%
-16.7%
Q3 2018$1,149,000
+11.8%
39,972
+45.7%
0.01%0.0%
Q2 2018$1,028,00027,4420.01%
Other shareholders
INTERSECT ENT INC shareholders Q1 2019
NameSharesValueWeighting ↓
KOPP INVESTMENT ADVISORS LLC 238,698$3,781,0003.74%
PURA VIDA INVESTMENTS, LLC 275,000$4,356,0001.32%
Broadfin Capital, LLC 638,600$10,115,0000.91%
Aisling Capital LLC 248,498$3,936,0000.81%
Bellevue Group AG 205,325$3,252,0000.59%
Iguana Healthcare Management, LLC 180,000$2,852,0000.51%
Rock Springs Capital Management LP 345,000$5,465,0000.34%
SECTORAL ASSET MANAGEMENT INC 168,140$2,663,0000.26%
FORMULA GROWTH LTD 62,213$985,0000.22%
MENTA CAPITAL LLC 111,915$1,773,0000.17%
View complete list of INTERSECT ENT INC shareholders